4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Laurus Labs Limited (LAURUSLABS) operates in the Drug Manufacturers - Specialty & Generic industry and is headquartered in Hyderabad, India with about 7,059 employees. Its market capitalization is roughly ₹1.06 trillion. In the fiscal year ended 2026-03-31, LAURUSLABS reported ₹67.2B in revenue and ₹8.9B in net income.
Laurus Labs Limited, together with its subsidiaries, manufactures and sells medicines and active pharmaceutical ingredients (APIs) in India and internationally.
Interactive charts & full statements →
| Income statement | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Total Revenue | ₹67.2B | ₹55.1B | ₹50.0B | ₹60.1B | — |
| Gross Profit | ₹39.6B | ₹29.7B | ₹25.0B | ₹31.7B | — |
| Operating Income (EBIT) | ₹13.1B | ₹6.3B | ₹3.9B | ₹12.9B | — |
| Net Income | ₹8.9B | ₹3.6B | ₹1.6B | ₹7.9B | — |
INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|---|
| Total Revenue | ₹20.3B | ₹18.1B | ₹17.8B | ₹15.7B | ₹17.2B |
| Gross Profit | ₹12.7B | ₹11.1B | ₹10.8B | ₹9.3B | ₹9.4B |
| Operating Income (EBIT) | ₹5.1B | ₹3.9B | ₹3.6B | ₹2.7B | ₹3.1B |
| Net Income | ₹3.7B | ₹2.8B | ₹2.5B | ₹1.6B | ₹2.3B |
INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Dividends Paid | (₹863M) | (₹431M) | (₹862M) | (₹1.1B) | — |
INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Total Assets | ₹105.1B | ₹93.4B | ₹83.9B | ₹76.6B | — |
| Total Liabilities | ₹50.8B | ₹47.3B | ₹42.7B | ₹36.1B | — |
INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive LAURUSLABS viewer.
This page in other languages: עברית · Русский · Español · Português · 中文 · العربية · Français · Italiano · 日本語 · Deutsch · فارسی · हिन्दी
About TickerBase · Data methodology & sources · Privacy · Terms